James Stuart Ferriss, MD

Professional Titles

• Director, F.J. Montz Gynecologic Oncology Fellowship Program

Primary Academic Title

Associate Professor of Gynecology and Obstetrics

Background

Videos

• Dr. Stuart Ferriss | Gynecologic Oncologist

Contact for Research Inquiries

600 N. Wolfe St
Phipps 281
Baltimore, MD 21287

Research Summary

Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education.

PubMed

https://www.ncbi.nlm.nih.gov/myncbi/james.ferriss.1/bibliography/public/

Selected Publications

• Ferriss JS, Java J, Bookman MA, Fleming GF, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Burger RA. Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study. Gynecol Oncol. 2015 Oct;139(1):17-22. PMID: 26216729.

• Guitarte C, Grant J, Zhao H, Wang S, Ferriss JS, Hernandez E. Incisional hernia formation and associated risk factors on a gynecologic oncology service: an exploratory analysis. Arch Gynecol Obstet. 2016;1–7. PMID: 27101367.

• Igwe E, Woodburn J, Davolos J, Shollenberger C, Miller S, Hernandez E, Ferriss JS. Patient Perceptions and Willingness to Participate in Clinical Trials. Gynecol Oncol. 2016 Sep;142(3):520-4. PMID: 27372403.

• Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov-Dec;16(6):11441151. PMID: 28958736

• Jordan SE, Stone D, Yu D, Ferriss JS, Hernandez E, Rubin S. Blood Loss from Robotic Assisted Hysterectomy. J Gynecol Surg 2017 33(2):47-50.

Honors

• Excellence in Medical Student Teaching, Department of Women's Health, UT Austin, 6/1/17
• Top Doctor, Austin Monthly Magazine, 1/1/17
• Academic Scholars & Leaders, Association of Professors in Gynecology & Obstetrics, 1/1/17
• Fellow American College of Surgeons, 6/1/14
• Young Investigator Award, Gynecologic Oncology Group, 2/1/13
• Fellow American College of Obstetricians and Gynecologists, 12/9/11

Lectures & Presentations

• A Pilot Predictive Model for the Ob/Gyn Residency Match, Invited Presentation., Academic Scholars and Leaders session of the Association of Professors in Gynecology and Obstetrics, National Harbor, MD, 3/3/18
• Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers., Speaker, Society of Gynecologic Oncology, Tampa, FL, 3/23/14
• Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: An NRG oncology/Gynecologic Oncology Group (GOG) study., Invited Presentation., American Society of Clinical Oncology Annual Meeting, Chicago, IL, 6/4/18
• The CARE study: Communicating about research with empathy, Panel Presentation, National Communication Association Convention, Salt Lake City, UT, 11/8/18

Memberships

• NRG Oncology
• Mid-Atlantic Gynecologic Oncology Society (MAGOS)
• American Society of Clinical Oncology (ASCO)
• American College of Obstetricians and Gynecologists (ACOG)
• The American College of Surgeons (ACS)
• Society of Gynecologic Oncology

Professional Activities

• American Society of Clinical Oncology, Meeting and Member Publications Board, 7/1/23
• Current Treatment Options in Oncology, Section Editor, 8/1/21
• SGO Program Director's Network, Co-Chair, 3/15/22 - 3/15/25